Suppr超能文献

黄斑毛细血管扩张症(MacTel)自然史研究参与者的基线特征。MacTel项目报告第2号。

Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2.

作者信息

Clemons Traci E, Gillies Marc C, Chew Emily Y, Bird Alan C, Peto Tunde, Figueroa Maria J, Harrington Molly W

机构信息

The EMMES Corporation, Rockville, MD 20850, USA.

出版信息

Ophthalmic Epidemiol. 2010 Jan-Feb;17(1):66-73. doi: 10.3109/09286580903450361.

Abstract

PURPOSE

To describe the baseline characteristics of a large international cohort of patients with macular telangiectasia type 2 (MacTel Type 2) in anticipation of a longitudinal natural history study to evaluate structural and functional changes, identify potential risk factors and related outcomes.

METHODS

Images including fundus photographs, fluorescein angiograms, optical coherence tomography and fundus autofluorescence were collected. A grading system for MacTel type 2 was developed by the central reading center to evaluate lesion characteristics. Relationships between lesion characteristics and visual acuity were evaluated.

RESULTS

A total of 310 participants have been enrolled in the study. The mean time since diagnosis was 3 years (range 0 to 25 years). The mean age at the baseline examination was 61 +/- 9 years. The mean visual acuity in the better eye was approximately 20/32 Snellen equivalents and approximately 20/50 in the worse eye. The visual acuity in the better eye of half of the participants was 20/32 or better. We found some relationships between visual acuity and lesions characteristic of MacTel Type 2.

CONCLUSIONS

This is the first large-scale study of patients with MacTel Type 2. More than half of the patients had 20/32 or better vision in their better eye, which is a sign that decreased function in these participants may not be reflected in central visual acuity. These findings highlight the limitation of using visual acuity measurements as a measure of function and as an outcome measure in potential clinical trials in patients with MacTel Type 2.

摘要

目的

为了开展一项纵向自然史研究,以评估黄斑毛细血管扩张症2型(MacTel 2型)患者的结构和功能变化、识别潜在风险因素及相关结局,本研究描述了一个大型国际队列患者的基线特征。

方法

收集了包括眼底照片、荧光素血管造影、光学相干断层扫描和眼底自发荧光在内的图像。中央阅片中心开发了一种MacTel 2型分级系统,以评估病变特征。评估了病变特征与视力之间的关系。

结果

共有310名参与者纳入本研究。自诊断以来的平均时间为3年(范围0至25年)。基线检查时的平均年龄为61±9岁。较好眼的平均视力约为20/32 Snellen等效视力,较差眼约为20/50。一半参与者较好眼的视力为20/32或更好。我们发现了MacTel 2型的视力与病变特征之间的一些关系。

结论

这是首次对MacTel 2型患者进行的大规模研究。超过一半的患者较好眼的视力为20/32或更好,这表明这些参与者的功能下降可能未在中心视力中得到体现。这些发现凸显了在MacTel 2型患者潜在临床试验中,将视力测量用作功能指标和结局指标的局限性。

相似文献

2
The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project.
Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4340-6. doi: 10.1167/iovs.08-1749. Epub 2008 Jun 27.
5
Familial asymptomatic macular telangiectasia type 2.
Ophthalmology. 2009 Dec;116(12):2422-9. doi: 10.1016/j.ophtha.2009.05.010. Epub 2009 Oct 7.
6
Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area: MacTel Project Report Number 8.
Ophthalmology. 2020 Nov;127(11):1539-1548. doi: 10.1016/j.ophtha.2020.03.040. Epub 2020 Apr 21.
7
Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
Ophthalmol Retina. 2019 Jun;3(6):516-522. doi: 10.1016/j.oret.2019.01.022. Epub 2019 Feb 6.
8
Radial Hemorrhage in Henle Layer in Macular Telangiectasia Type 2.
JAMA Ophthalmol. 2018 Oct 1;136(10):1182-1185. doi: 10.1001/jamaophthalmol.2018.2979.
10
Retinal vascular density evaluated by optical coherence tomography angiography in macular telangiectasia type 2.
Int Ophthalmol. 2019 Oct;39(10):2245-2256. doi: 10.1007/s10792-018-01060-x. Epub 2019 Jan 3.

引用本文的文献

1
Enhanced Macular Telangiectasia Type 2 Detection: Leveraging Self-Supervised Learning and Ensemble Models.
Ophthalmol Sci. 2025 Jan 13;5(4):100710. doi: 10.1016/j.xops.2025.100710. eCollection 2025 Jul-Aug.
2
Genetic Background of Macular Telangiectasia Type 2.
Int J Mol Sci. 2025 Jan 15;26(2):684. doi: 10.3390/ijms26020684.
4
Retinal pigment epithelial cells reduce vascular leak and proliferation in retinal neovessels.
Angiogenesis. 2024 Nov 27;28(1):1. doi: 10.1007/s10456-024-09954-4.
5
Progressive inner retinal neurodegeneration in non-proliferative macular telangiectasia type 2.
Br J Ophthalmol. 2025 Feb 24;109(3):401-407. doi: 10.1136/bjo-2023-325115.
8
High-Resolution Imaging in Macular Telangiectasia Type 2: Case Series and Literature Review.
Diagnostics (Basel). 2024 Jun 25;14(13):1351. doi: 10.3390/diagnostics14131351.
10
Longitudinal anatomical and visual outcome of macular telangiectasia type 2 in Asian patients.
Sci Rep. 2023 Nov 2;13(1):18954. doi: 10.1038/s41598-023-46394-4.

本文引用的文献

1
Familial asymptomatic macular telangiectasia type 2.
Ophthalmology. 2009 Dec;116(12):2422-9. doi: 10.1016/j.ophtha.2009.05.010. Epub 2009 Oct 7.
2
3
The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project.
Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4340-6. doi: 10.1167/iovs.08-1749. Epub 2008 Jun 27.
4
Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia.
Retina. 2008 Jun;28(6):808-16. doi: 10.1097/IAE.0b013e31816d81aa.
5
ATM gene variants in patients with idiopathic perifoveal telangiectasia.
Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3806-11. doi: 10.1167/iovs.07-1357. Epub 2008 May 23.
6
Idiopathic macular telangiectasia.
Arch Ophthalmol. 2006 Apr;124(4):450-60. doi: 10.1001/archopht.124.4.450.
7
Histopathologic study of presumed parafoveal telangiectasis.
Retina. 1999;19(4):332-5. doi: 10.1097/00006982-199907000-00011.
9
New visual acuity charts for clinical research.
Am J Ophthalmol. 1982 Jul;94(1):91-6.
10
Idiopathic juxtafoveolar retinal telangiectasis.
Arch Ophthalmol. 1982 May;100(5):769-80. doi: 10.1001/archopht.1982.01030030773010.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验